Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Aspire Biopharma Holdings, Inc. (ASBP) Weighted-Average Shares Outstanding (Diluted) data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-12.54M |
|
-- |
|
-- |
|
$3.09M |
|
$-3.09M |
|
$-9.45M |
|
$-12.54M |
|
$-12.54M |
|
$-12.54M |
|
$-12.54M |
|
$-12.54M |
|
$-12.54M |
|
$-3.09M |
|
$-3.09M |
|
-- |
|
|
Weighted-Average Shares Outstanding (Diluted) |
-- |
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.05M |
|
-- |
|
$6.67M |
|
$6.71M |
|
$15.62M |
|
-- |
|
$6.67M |
|
$22.28M |
|
$-15.57M |
|
$-15.57M |
|
$-15.57M |
|
7.19M |
|
| Cash Flow Statement Financials | |
$-2.05M |
|
$13.78M |
|
$-11.73M |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
80.52% |
|
80.52% |
|
-186.73% |
|
80.52% |
|
$-2.17 |
|
-- |
|
-- |
|